national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference


Overview | Agenda | Promotional Opportunities | Grantors & Exhibitors
Speaking Proposals | Administration | Past Events | Webcast Log In | Contact Us | Home




OVERVIEW

The long-awaited Final Rule for the Physician Payments Sunshine Act has finally reached the Office of Management and Budget (OMB) for review and is expected to be released by year's end. Despite numerous delays in implementing the regulations, the Centers for Medicare and Medicaid Services (CMS) has repeatedly stated that it hopes to begin data collection in 2013. The Fifth Annual Summit on Disclosure Transparency and Aggregate Spend for Drug, Device and Biotech Companies will offer pharmaceutical and medical device professionals the first opportunity to assess the Final Rule with the help of senior government regulators, as well as an array of industry experts and leading consultants who have been in the vanguard of building and implementing aggregate spend solutions.

The Summit will also provide a comprehensive update of the rapidly evolving transparency requirements now taking shape across the globe and offer timely advice on creating a global aggregate spend and disclosure program. In-house experts will share their experience on a wide array of emerging best practices ranging from project management to building scalability and sustainability. Panels of in-house and outside experts will weigh in on key topics such as drug sample compliance, R&D and clinical trials compliance, Fair Market Value, and advanced operational issues.

WHO SHOULD ATTEND
  • Aggregate Spend Reporting
  • Ethics and Compliance
  • Regulatory Affairs
  • Business Analytics
  • Commercial Operations
  • Corporate Communications
  • Legal
  • Finance
  • Audit
ABOUT THE PHARMACEUTICAL COMPLIANCE FORUM (PCF)

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest researchbased pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field. PCF also sponsors a three-day compliance congress each Fall. For membership information, contact Tim Bower at 215-599-6617 or via email at info@PharmaComplianceForum.org. Please visit their website at www.PharmaComplianceForum.org.




Overview | Agenda | Promotional Opportunities | Grantors & Exhibitors
Speaking Proposals | Administration | Past Events | Webcast Log In | Contact Us | Home



© Health Care Conference Administrators
Contact Webmaster